Nutriband Inc. (NTRB)
NTRB Stock Price Chart
Explore Nutriband Inc. interactive price chart. Choose custom timeframes to analyze NTRB price movements and trends.
NTRB Company Profile
Discover essential business fundamentals and corporate details for Nutriband Inc. (NTRB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Oct 2021
Employees
13.00
Website
https://nutriband.comCEO
Gareth Sheridan
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
NTRB Financial Timeline
Browse a chronological timeline of Nutriband Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 May 2026
Upcoming earnings on 2 Dec 2025
EPS estimate is -$0.19.
Earnings released on 9 Sept 2025
EPS came in at -$2.12 falling short of the estimated -$0.17 by -1.15K%, while revenue for the quarter reached $622.45K , missing expectations by -11.71%.
Earnings released on 30 May 2025
EPS came in at -$0.12 surpassing the estimated -$0.13 by +7.69%, while revenue for the quarter reached $667.43K , missing expectations by -5.33%.
Earnings released on 28 Apr 2025
EPS came in at -$0.18 falling short of the estimated -$0.12 by -50.00%, while revenue for the quarter reached $642.38K , missing expectations by -9.52%.
Earnings released on 3 Dec 2024
EPS came in at -$0.12 , while revenue for the quarter reached $645.80K .
Earnings released on 3 Sept 2024
EPS came in at -$0.12 , while revenue for the quarter reached $442.83K .
Earnings released on 31 May 2024
EPS came in at -$0.21 , while revenue for the quarter reached $408.53K .
Earnings released on 30 Apr 2024
EPS came in at -$0.16 , while revenue for the quarter reached $524.61K .
Earnings released on 12 Dec 2023
EPS came in at -$0.22 , while revenue for the quarter reached $427.84K .
Earnings released on 11 Sept 2023
EPS came in at -$0.11 , while revenue for the quarter reached $655.93K .
Earnings released on 9 Jun 2023
EPS came in at -$0.13 , while revenue for the quarter reached $476.93K .
Earnings released on 26 Apr 2023
EPS came in at -$0.21 falling short of the estimated -$0.05 by -320.00%, while revenue for the quarter reached $527.54K , missing expectations by -21.85%.
Earnings released on 2 Dec 2022
EPS came in at -$0.14 falling short of the estimated -$0.07 by -100.00%, while revenue for the quarter reached $618.00K , beating expectations by +9.74%.
Earnings released on 7 Sept 2022
EPS came in at -$0.12 falling short of the estimated -$0.07 by -71.43%, while revenue for the quarter reached $456.15K , beating expectations by +0.01%.
Stock split effective on 15 Aug 2022
Shares were split 7 : 6 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 12 Aug 2022
Shares were split 583 : 500 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 May 2022
EPS came in at -$0.08 falling short of the estimated -$0.06 by -33.33%, while revenue for the quarter reached $477.92K , beating expectations by 0.00%.
Earnings released on 29 Apr 2022
EPS came in at -$0.20 falling short of the estimated -$0.09 by -122.22%, while revenue for the quarter reached $491.89K , beating expectations by +7.93%.
Earnings released on 14 Dec 2021
EPS came in at -$0.23 falling short of the estimated -$0.03 by -574.88%, while revenue for the quarter reached $283.04K , missing expectations by -68.20%.
Earnings released on 3 Sept 2021
EPS came in at -$0.07 falling short of the estimated -$0.01 by -900.00%, while revenue for the quarter reached $213.74K , missing expectations by -88.89%.
Earnings released on 14 Jun 2021
EPS came in at -$0.04 , while revenue for the quarter reached $433.49K .
Earnings released on 2 Apr 2021
EPS came in at -$0.33 , while revenue for the quarter reached $348.09K .
Earnings released on 15 Dec 2020
EPS came in at -$0.01 falling short of the estimated -$0.01 by -75.13%, while revenue for the quarter reached $391.80K , missing expectations by -36.51%.
NTRB Stock Performance
Access detailed NTRB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.